These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 21517742)

  • 1. Targeting the human macrophage with combinations of drugs and inhibitors of Ca2+ and K+ transport to enhance the killing of intracellular multi-drug resistant Mycobacterium tuberculosis (MDR-TB)--a novel, patentable approach to limit the emergence of XDR-TB.
    Martins M
    Recent Pat Antiinfect Drug Discov; 2011 May; 6(2):110-7. PubMed ID: 21517742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective therapy with the neuroleptic thioridazine as an adjunct to second line of defence drugs, and the potential that thioridazine offers for new patents that cover a variety of "new uses".
    Amaral L; Viveiros M; Molnar J; Kristiansen JE
    Recent Pat Antiinfect Drug Discov; 2011 May; 6(2):84-7. PubMed ID: 21548876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global clinical trials for the treatment of TB with thioridazine.
    Boeree MJ
    Recent Pat Antiinfect Drug Discov; 2011 May; 6(2):99-103. PubMed ID: 21548879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. It is anticipated that as is usually the case, financial motivation will move TZ from its current status “potential anti-MDR/XDR agent,” to one that will cure MDR and XDR TB. Foreword.
    Amaral L
    Recent Pat Antiinfect Drug Discov; 2011 May; 6(2):76. PubMed ID: 21796848
    [No Abstract]   [Full Text] [Related]  

  • 5. The broad-spectrum antimycobacterial activities of phenothiazines, InVitro: somewhere in all of this there may be patentable potentials.
    van Ingen J
    Recent Pat Antiinfect Drug Discov; 2011 May; 6(2):104-9. PubMed ID: 21517740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New patentable use of an old neuroleptic compound thioridazine to combat tuberculosis: a gene regulation perspective.
    Dutta NK; Mazumdar K; Dastidar SG; Karakousis PC; Amaral L
    Recent Pat Antiinfect Drug Discov; 2011 May; 6(2):128-38. PubMed ID: 21517741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting human macrophages for enhanced killing of intracellular XDR-TB and MDR-TB.
    Martins M; Viveiros M; Couto I; Amaral L
    Int J Tuberc Lung Dis; 2009 May; 13(5):569-73. PubMed ID: 19383188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy Of XDR TB with thioridazine a drug beyond patent protection but eligible for patent "as new use".
    Amaral L; Molnar J
    Recent Pat Antiinfect Drug Discov; 2010 Jun; 5(2):109-14. PubMed ID: 20156179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in the discovery of new drugs for Mycobacterium tuberculosis therapy with a glance at resistance.
    Lohrasbi V; Talebi M; Bialvaei AZ; Fattorini L; Drancourt M; Heidary M; Darban-Sarokhalil D
    Tuberculosis (Edinb); 2018 Mar; 109():17-27. PubMed ID: 29559117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why thioridazine in combination with antibiotics cures extensively drug-resistant Mycobacterium tuberculosis infections.
    Amaral L; Viveiros M
    Int J Antimicrob Agents; 2012 May; 39(5):376-80. PubMed ID: 22445204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XDR-TB, what is it; how is it treated; and why is therapeutic failure so high?
    Gillespie SH; Singh K
    Recent Pat Antiinfect Drug Discov; 2011 May; 6(2):77-83. PubMed ID: 21595627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Old antibiotics for emerging multidrug-resistant/extensively drug-resistant tuberculosis (MDR/XDR-TB).
    Brouqui P; Quenard F; Drancourt M
    Int J Antimicrob Agents; 2017 May; 49(5):554-557. PubMed ID: 28336312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promising therapy of XDR-TB/MDR-TB with thioridazine an inhibitor of bacterial efflux pumps.
    Amaral L; Martins M; Viveiros M; Molnar J; Kristiansen JE
    Curr Drug Targets; 2008 Sep; 9(9):816-9. PubMed ID: 18781927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
    Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic investigation of resistance via drug-inactivating enzymes in Mycobacterium tuberculosis.
    Kashyap A; Singh PK; Silakari O
    Drug Metab Rev; 2018 Nov; 50(4):448-465. PubMed ID: 30343607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic drugs in the treatment of tuberculosis: Minimal inhibitory concentrations of different phenothiazines against Mycobacterium tuberculosis.
    Vesenbeckh S; Krieger D; Bettermann G; Schönfeld N; Bauer TT; Rüssmann H; Mauch H
    Tuberculosis (Edinb); 2016 May; 98():27-9. PubMed ID: 27156615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of drug resistance in Mycobacterium tuberculosis.
    Zhang Y; Yew WW
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1320-30. PubMed ID: 19861002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why and how thioridazine in combination with antibiotics to which the infective strain is resistant will cure totally drug-resistant tuberculosis.
    Amaral L; Molnar J
    Expert Rev Anti Infect Ther; 2012 Aug; 10(8):869-73. PubMed ID: 23030326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis.
    Blöndal K; Viiklepp P; Guðmundsson LJ; Altraja A
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1228-33. PubMed ID: 22748131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms by which thioridazine in combination with antibiotics cures extensively drug-resistant infections of pulmonary tuberculosis.
    Amaral L; Molnar J
    In Vivo; 2014; 28(2):267-71. PubMed ID: 24632985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.